Riskpilot← Back to searchSign inGet full accessVITALIV AS
ASActiveOrg 913034945Granåsbakken 7, 2827 HunndalenOther non-specialised retail sale · NACE 4712Est. 20145 employeeswww.vitaliv.no
Revenue 2024
NOK 24,8M
+12% vs 2023
EBITDA margin
9.8%
+259% vs 2023
Equity ratio
73.9%
Financial strength
Net profit 2024
NOK 1,2M
+177% vs 2023
| Revenue | NOK 24,8M | +12% |
| EBITDA | NOK 2,4M | +259% |
| Net profit | NOK 1,2M | +177% |
| Total assets | NOK 10,4M | +1% |
| Equity | NOK 7,7M | +17% |
| Employees | 5 | — |
Legal name
VITALIV AS
Org number
913034945
Legal form
Aksjeselskap
NACE code
4712 · Other non-specialised retail sale
Founded
8. januar 2014
Share capital
NOK 58 860
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Adis arifagic
Company purpose
Selge helsekostprodukter og naturlegemidler, samt annen virksomhet som faller inn under dette.
Address
Granåsbakken 7, 2827 Hunndalen
Phone
+4722008000
Email
kundeservice@vitaliv.no
Website
www.vitaliv.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 61 938 | 46 838 | 25 161 | 22 071 | 24 764 |
| Staff expenses | −11 214 | −4 825 | −1 512 | −1 607 | −1 768 |
| EBITDA | −3 516 | 1 113 | 2 607 | −1 519 | 2 422 |
| Depreciation & amort. | −84 | −86 | −63 | −62 | −32 |
| EBIT | −3 600 | 1 027 | 2 544 | −1 581 | 2 389 |
| Net financials | −2 191 | −969 | −2 153 | −317 | −912 |
| Profit before tax | −5 791 | 58 | 391 | −1 897 | 1 478 |
| Tax | −1 259 | 92 | 102 | −405 | 325 |
| Net profit | −4 532 | −34 | 289 | −1 492 | 1 153 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 15 859 | 14 585 | 11 401 | 10 293 | 10 363 |
| Equity | 9 427 | 9 393 | 8 026 | 6 534 | 7 661 |
| Long-term debt | 1 084 | 941 | 0 | 0 | 0 |
| Short-term debt | 5 348 | 4 250 | 3 375 | 3 759 | 2 703 |
| Total debt | 6 432 | 5 192 | 3 375 | 3 759 | 2 703 |
EBITDA margin
9.8%
This company
15.8%
Market median
-38% vs market
20202024
Equity ratio
73.9%
This company
38.2%
Market median
+93% vs market
20202024
Return on equity
15.1%
This company
18.4%
Market median
+18% vs market
20202024
Net profit margin
4.7%
This company
8.1%
Market median
-42% vs market
20202024
Asset turnover
2.39×
This company
1.12×
Market median
+113% vs market
20202024
Debt / equity
0.35×
This company
0.62×
Market median
+44% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2021 | |
| Former (1) | ||
| Deputy Chairman | 2019 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50.97% | 50.97% | 2024 | |
Alexey Golovkin | Company | 24.52% | 24.52% | 2024 |
| Individual | 24.52% | 24.52% | 2022 | |
| Individual | 24.52% | 24.52% | 2023 | |
Daniel Dmitrii Berg Vasilev | Company | 24.52% | 24.52% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of VITALIV AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Adis Arifagic | Chairman | 0 companies |
| Dmitrii Vasilev | Deputy Chairman | 0 companies |